Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients

American Journal of Psychiatry

Volumn 165, Issue 12, 2008, Pages 1594-1603

  Bullock, W Michael ^b   Cardon, Karen ^b   Bustillo, Juan ^b   Roberts, Rosalinda C ^b   Perrone Bizzozero, Nora I ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA6; 4 AMINOBUTYRIC ACID A RECEPTOR BETA3; 4 AMINOBUTYRIC ACID A RECEPTOR DELTA; 4 AMINOBUTYRIC ACID CARRIER; CHLORPROMAZINE; CLOZAPINE; DRUG VEHICLE; FLUPHENAZINE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; GLUTAMATE RECEPTOR 6; HALOPERIDOL; KAINIC ACID RECEPTOR; KAINIC ACID RECEPTOR SUBUNIT 2; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2C; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2D; NEURONAL NITRIC OXIDE SYNTHASE; OLANZAPINE; PARVALBUMIN; PERPHENAZINE; RECEPTOR SUBUNIT; RISPERIDONE; THIORIDAZINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CELLULAR DISTRIBUTION; CEREBELLUM; GABAERGIC TRANSMISSION; GENE EXPRESSION REGULATION; GRANULE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIMBIC SYSTEM; MALE; NEUROMODULATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

ADULT; AGED; CEREBELLUM; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION; GLUTAMATE DECARBOXYLASE; GRANULOCYTES; HUMANS; MALE; MIDDLE AGED; NEUROTRANSMITTER AGENTS; RECEPTORS, GABA-A; RNA, MESSENGER; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

EID: 56649099232     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2008.07121845     Document Type: Article

References (40)

1. Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB: Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry 2005; 57:252-260
2. Akbarian S, Huang HS: Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res Rev 2006; 52:293-304
3. Lewis DA, Hashimoto T, Volk DW: Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 2005; 6:312-324
4. Benes FM, Berretta S: GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001; 25:1-27
5. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA: Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 2000; 57:237-245
6. Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, Sampson AR, Lewis DA: Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 2003; 23:6315-6326
7. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE Jr, Jones EG: Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 1995; 52:258-266
8. Heckers S, Stone D, Walsh J, Shick J, Koul P, Benes FM: Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch Gen Psychiatry 2002; 59:521-529
9. Woo TU, Walsh JP, Benes FM: Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 2004; 61:649-657
10. 67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 2000; 57:1061-1069
11. Fatemi SH, Stary JM, Earle JA, Araghi-Niknam M, Eagan E: GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and reelin proteins in cerebellum. Schizophr Res 2005; 72:109-122
12. Volk D, Austin M, Pierri J, Sampson A, Lewis D: GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am J Psychiatry 2001; 158:256-265
13. Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP: Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 1992; 12:924-929
14. A receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience 1996; 75:1021-1031
15. Volk DW, Pierri JN, Fritschy JM, Auh S, Sampson AR, Lewis DA: Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb Cortex 2002; 12:1063-1070
16. 67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol Psychiatry 2005; 10:581-588
17. 67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry 2007; 12:854-869
18. Schmahmann JD, Sherman JC: The cerebellar cognitive affective syndrome. Brain 1998; 121(pt 4):561-579
19. Ramnani N: The primate cortico-cerebellar system: anatomy and function. Nat Rev Neurosci 2006; 7:511-522
20. Kim JJ, Mohamed S, Andreasen NC, O'Leary DS, Watkins GL, Boles Ponto LL, Hichwa RD: Regional neural dysfunctions in chronic schizophrenia studied with positron emission tomography. Am J Psychiatry 2000; 157:542-548
21. Potkin SG, Alva G, Fleming K, Anand R, Keator D, Carreon D, Doo M, Jin Y, Wu JC, Fallon JH: A PET study of the pathophysiology of negative symptoms in schizophrenia. Am J Psychiatry 2002; 159:227-237
22. Malaspina D, Harkavy-Friedman J, Corcoran C, Mujica-Parodi L, Printz D, Gorman JM, Van Heertum R: Resting neural activity distinguishes subgroups of schizophrenia patients. Biol Psychiatry 2004; 56:931-937
23. Eastwood SL, Law AJ, Everall IP, Harrison PJ: The axonal chemorepellant Semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology. Mol Psychiatry 2003; 8:148-155
24. Paz RD, Andreasen NC, Daoud SZ, Conley R, Roberts R, Bustillo J, Perrone-Bizzozero NI: Increased expression of activity-dependent genes in cerebellar glutamatergic neurons of patients with schizophrenia. Am J Psychiatry 2006; 163:1829-1831
25. Bustillo J, Barrow R, Paz R, Tang J, Seraji-Bozorgzad N, Moore GJ, Bolognani F, Lauriello J, Perrone-Bizzozero N, Galloway MP: Long-term treatment of rats with haloperidol: lack of an effect on brain N-acetyl aspartate levels. Neuropsychopharmacology 2006; 31:751-756
26. Bai O, Zhang H, Li XM: Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus. Brain Res 2004; 1010:81-86
27. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C[T]) method. Methods 2001; 25:402-408
28. Akbarian S, Sucher NJ, Bradley D, Tafazzoli A, Trinh D, Hetrick WP, Potkin SG, Sandman CA, Bunney WE Jr, Jones EG: Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci 1996; 16:19-30
29. Scherzer CR, Landwehrmeyer GB, Kerner JA, Standaert DG, Hollingsworth ZR, Daggett LP, Velicelebi G, Penney JB Jr, Young AB: Cellular distribution of NMDA glutamate receptor subunit mRNAs in the human cerebellum. Neurobiol Dis 1997; 4:35-46
30. Baader SL, Schilling K: Glutamate receptors mediate dynamic regulation of nitric oxide synthase expression in cerebellar granule cells. J Neurosci 1996; 16:1440-1449
31. Berthele A, Platzer S, Laurie DJ, Weis S, Sommer B, Zieglgansberger W, Conrad B, Tolle TR: Expression of metabotropic glutamate receptor subtype mRNA (mGluR1-8) in human cerebellum. Neuroreport 1999; 10:3861-3867
32. Wall MJ: Endogenous nitric oxide modulates GABAergic transmission to granule cells in adult rat cerebellum. Eur J Neurosci 2003; 18:869-878
33. Porter RH, Eastwood SL, Harrison PJ: Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia. Brain Res 1997; 751:217-231
34. Andreasen NC, Nopoulos P, O'Leary DS, Miller DD, Wassink T, Flaum M: Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry 1999; 46:908-920
35. Ito M: Cerebellar circuitry as a neuronal machine. Prog Neurobiol 2006; 78:272-303
36. Takayama C, Inoue Y: Developmental expression of GABA transporter-1 and 3 during formation of the GABAergic synapses in the mouse cerebellar cortex. Brain Res Dev Brain Res 2005; 158:41-49
37. Bastianelli E: Distribution of calcium-binding proteins in the cerebellum. Cerebellum 2003; 2:242-262
38. Homayoun H, Moghaddam B: NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci 2007; 27:11496-11500
39. Meador-Woodruff JH, Davis KL, Haroutunian V: Abnormal kainate receptor expression in prefrontal cortex in schizophrenia. Neuropsychopharmacology 2001; 24:545-552
40. Ho BC, Mola C, Andreasen NC: Cerebellar dysfunction in neuroleptic naive schizophrenia patients: clinical, cognitive, and neuroanatomic correlates of cerebellar neurologic signs. Biol Psychiatry 2004; 55:1146-1153